Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPE | Q05469 | 5/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | UCHL1 | P09936 | 1/20 | 0.36 |
| ▸ | P2RX3 | P56373 | 4/20 | 0.35 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31395494 | 0.85 | LIPE (0.42) | LIPEMEN1KMT2A | |
| SCHEMBL1360468 | 0.84 | TDP1 (0.44) | LIPEMEN1KMT2ADGAT1L3MBTL1 | |
| SCHEMBL25426624 | 0.83 | LIPE (0.55) | LIPEMAPT | |
| SCHEMBL580807 | 0.83 | MEN1 (0.45) | LIPEMEN1KMT2AMAPT | |
| SCHEMBL25340238 | 0.82 | LIPE (0.40) | LIPEMEN1KMT2AMAPT | |
| SCHEMBL25955360 | 0.82 | LIPE (0.40) | LIPEMEN1KMT2AMAPT | |
| SCHEMBL365301 | 0.79 | L3MBTL1 (0.36) | LIPEUCHL1L3MBTL1 | |
| SCHEMBL29900384 | 0.79 | L3MBTL1 (0.36) | LIPEUCHL1L3MBTL1 | |
| SCHEMBL30292561 | 0.76 | APLNR (0.38) | LIPEUCHL1 | |
| SCHEMBL1484864 | 0.76 | APLNR (0.38) | LIPEUCHL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023146513-A1 | COMPOUNDS AND METHODS OF USE THEREOF | VIVACE THERAPEUTICS, INC. (US) | 2023-08-03 | — | — | WO | disclosed |